Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

SEC Filings

Trovagene is publicly traded on the NASDAQ stock exchange under the symbol TROV.

NASDAQTROV
FormDescriptionDateFormat
EFFECTNotice from the SEC of registration effectivenessMay 21, 2019View HTMLDownload DOCDownload PDF
POS AMPost-effective amendment to an S-Type filingMay 21, 2019View HTMLDownload DOCDownload PDFDownload XLS
DOfficial notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the ActMay 20, 2019View HTMLDownload DOCDownload PDF
POS AMPost-effective amendment to an S-Type filingMay 17, 2019View HTMLDownload DOCDownload PDFDownload XLS
POS AMPost-effective amendment to an S-Type filingMay 14, 2019View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3May 13, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 13, 2019View HTMLDownload DOCDownload PDFDownload XLS
POS AMPost-effective amendment to an S-Type filingMay 10, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 8, 2019View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionMay 7, 2019View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
POS AMPost-effective amendment to an S-Type filingApr 25, 2019View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 23, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 23, 2019View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 19, 2019View HTMLDownload DOCDownload PDFDownload XLS
DOfficial notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the ActApr 10, 2019View HTMLDownload DOCDownload PDF
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 5, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 5, 2019View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 3, 2019View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventApr 2, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 1, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 13, 2019View HTMLDownload DOCDownload PDFDownload XLS
424B3Form of prospectus reflecting facts events constituting substantive change from last formMar 12, 2019View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 12, 2019View HTMLDownload DOCDownload PDFDownload XLS
EFFECTNotice from the SEC of registration effectivenessMar 11, 2019View HTMLDownload DOCDownload PDF
S-3/APre-effective amendment to an S-3 filingMar 8, 2019View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-91